A Study of 2141-V11 in Combination With Standard Treatments in People With Prostate Cancer
NCT06347705
·
clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
57
Enrollment
OTHER
Sponsor class
Conditions
Prostate Cancer
Interventions
BIOLOGICAL:
2141-V11 Antibody
Sponsor
Memorial Sloan Kettering Cancer Center